GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Famciclovir

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Famvir - labeled renal guidance

Product / population
Famciclovir (Famvir), oral tablets; generic label comparison
Renal method
Creatinine clearance (CrCl), mL/min
Source revision
DailyMed SPL version 4, posted Jan 16, 2026
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Famvir - product and source limitations

The RX source names Famvir. The separately linked prescribing information is for a generic famciclovir oral tablet of matching form and strength.

What to reconcile: The RX source names Famvir. The separately linked prescribing information is for a generic famciclovir oral tablet of matching form and strength.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Famvir - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Famciclovir (Famvir), oral tablets; generic label comparison

Renal method: Creatinine clearance (CrCl), mL/min
Source date: DailyMed SPL version 4, posted Jan 16, 2026
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2.1 and 2.3, Table 1

Limits that apply to these rows

The usual course is seven days. Genital and orolabial herpes use different regimens. The primary source is a matched generic oral tablet label.

Oral famciclovir for herpes zoster in immunocompetent adults
CrCl (mL/min) or modalityOral regimen
>=60500 mg every 8 hours
40-59500 mg every 12 hours
20-39500 mg every 24 hours
<20, off HD250 mg every 24 hours
Hemodialysis250 mg after each session
Read the retained text before reformatting

For immunocompetent adults with herpes zoster, use 500 mg every 8 hours at CrCl at least 60, every 12 hours at 40-59, and every 24 hours at 20-39 mL/min. Below 20, give 250 mg every 24 hours. In HD give 250 mg following each dialysis session. The usual course is seven days. Genital and orolabial herpes use different regimens. The primary source is a matched generic oral tablet label.

RDM74-famvir-official-1 · Source locator: Renal guidance: 2.1 and 2.3, Table 1

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min
Source date/version
DailyMed SPL version 4, posted Jan 16, 2026
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
7bd9c9bb94915aa96a74035a1a6cce7635658479580f96b4f048ba108571b54c

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=famciclovir&s1=RDM74-famvir-official&h1=a3f2bd3e195378ca3bc961683c134264acae67481ff3549a64cae59e95813563

Top